Genomic Alterations Caused by HPV Integration in a Cohort of Chinese Endocervical Adenocarcinomas

Overview

Journal Cancer Gene Ther

Specialties Genetics
Oncology
Pharmacology

Date 2021 Jan 5

PMID 33398034

Citations 6

Authors

Wenhui Li

Wanjun Lei

Xiaopei Chao

Xiaochen Song

Yalan Bi

Huanwen Wu

Ming Wu

Lei Li

Affiliations

Soon will be listed here.

Abstract

The association between human papillomavirus (HPV) integration and relevant genomic changes in uterine cervical adenocarcinoma is poorly understood. This study is to depict the genomic mutational landscape in a cohort of 20 patients. HPV+ and HPV- groups were defined as patients with and without HPV integration in the host genome. The genetic changes between these two groups were described and compared by whole-genome sequencing (WGS) and whole-exome sequencing (WES). WGS identified 2916 copy number variations and 743 structural variations. WES identified 6113 somatic mutations, with a mutational burden of 2.4 mutations/Mb. Six genes were predicted as driver genes: PIK3CA, KRAS, TRAPPC12, NDN, GOLGA6L4 and BAIAP3. PIK3CA, NDN, GOLGA6L4, and BAIAP3 were recognized as significantly mutated genes (SMGs). HPV was detected in 95% (19/20) of patients with cervical adenocarcinoma, 7 of whom (36.8%) had HPV integration (HPV+ group). In total, 1036 genes with somatic mutations were confirmed in the HPV+ group, while 289 genes with somatic mutations were confirmed in the group without HPV integration (HPV- group); only 2.1% were shared between the two groups. In the HPV+ group, GOLGA6L4 and BAIAP3 were confirmed as SMGs, while PIK3CA, NDN, KRAS, FUT1, and GOLGA6L64 were identified in the HPV- group. ZDHHC3, PKD1P1, and TGIF2 showed copy number amplifications after HPV integration. In addition, the HPV+ group had significantly more neoantigens. HPV integration rather than HPV infection results in different genomic changes in cervical adenocarcinoma.

Citing Articles

Recent advances in HPV biotechnology: understanding host-virus interactions and cancer progression - a review.

Yousaf S, Shehzadi A, Ahmad M, Asrar A, Ahmed I, Iqbal H Int J Surg. 2025; 110(12):8025-8036.

PMID: 39806745 PMC: 11634192. DOI: 10.1097/JS9.0000000000002117.

Cervical Cancer Stages, Human Papillomavirus Integration, and Malignant Genetic Mutations: Integrative Analysis of Datasets from Four Different Cohorts.

Mohammed F, Tune K, Jett M, Muhie S Cancers (Basel). 2023; 15(23).

PMID: 38067297 PMC: 10705285. DOI: 10.3390/cancers15235595.

Human papillomavirus associated cervical lesion: pathogenesis and therapeutic interventions.

Ye J, Zheng L, He Y, Qi X MedComm (2020). 2023; 4(5):e368.

PMID: 37719443 PMC: 10501338. DOI: 10.1002/mco2.368.

Subtypes analysis and prognostic model construction based on lysosome-related genes in colon adenocarcinoma.

Chen Y, Lu Y, Huang C, Wu J, Shao Y, Wang Z Front Genet. 2023; 14:1149995.

PMID: 37168510 PMC: 10166181. DOI: 10.3389/fgene.2023.1149995.

HPV integration generates a cellular super-enhancer which functions as ecDNA to regulate genome-wide transcription.

Tian R, Huang Z, Li L, Yuan J, Zhang Q, Meng L Nucleic Acids Res. 2023; 51(9):4237-4251.

PMID: 36864748 PMC: 10201430. DOI: 10.1093/nar/gkad105.

References

Cohen P, Jhingran A, Oaknin A, Denny L . Cervical cancer. Lancet. 2019; 393(10167):169-182. DOI: 10.1016/S0140-6736(18)32470-X. View

Pettersson B, Hellman K, Vaziri R, Andersson S, Hellstrom A . Cervical cancer in the screening era: who fell victim in spite of successful screening programs?. J Gynecol Oncol. 2011; 22(2):76-82. PMC: 3152759. DOI: 10.3802/jgo.2011.22.2.76. View

Bulk S, Visser O, Rozendaal L, Verheijen R, Meijer C . Cervical cancer in the Netherlands 1989-1998: Decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women. Int J Cancer. 2004; 113(6):1005-9. DOI: 10.1002/ijc.20678. View

Beiner M, Covens A . Surgery insight: radical vaginal trachelectomy as a method of fertility preservation for cervical cancer. Nat Clin Pract Oncol. 2007; 4(6):353-61. DOI: 10.1038/ncponc0822. View

Pirog E, Kleter B, Olgac S, Bobkiewicz P, Lindeman J, Quint W . Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol. 2000; 157(4):1055-62. PMC: 1850168. DOI: 10.1016/S0002-9440(10)64619-6. View

Pirog E, Lloveras B, Molijn A, Tous S, Guimera N, Alejo M . HPV prevalence and genotypes in different histological subtypes of cervical adenocarcinoma, a worldwide analysis of 760 cases. Mod Pathol. 2014; 27(12):1559-67. DOI: 10.1038/modpathol.2014.55. View

Holl K, Nowakowski A, Powell N, McCluggage W, Pirog E, De Souza S . Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias: Results from a European multinational epidemiological study. Int J Cancer. 2015; 137(12):2858-68. PMC: 5034816. DOI: 10.1002/ijc.29651. View

Molijn A, Jenkins D, Chen W, Zhang X, Pirog E, Enqi W . The complex relationship between human papillomavirus and cervical adenocarcinoma. Int J Cancer. 2015; 138(2):409-16. DOI: 10.1002/ijc.29722. View

Quint K, de Koning M, Geraets D, Quint W, Pirog E . Comprehensive analysis of Human Papillomavirus and Chlamydia trachomatis in in-situ and invasive cervical adenocarcinoma. Gynecol Oncol. 2009; 114(3):390-4. DOI: 10.1016/j.ygyno.2009.05.013. View

10.

Chen W, Molijn A, Enqi W, Zhang X, Jenkins D, Yu X . The variable clinicopathological categories and role of human papillomavirus in cervical adenocarcinoma: A hospital based nation-wide multi-center retrospective study across China. Int J Cancer. 2016; 139(12):2687-2697. DOI: 10.1002/ijc.30401. View

11.

Pirog E . Cervical Adenocarcinoma: Diagnosis of Human Papillomavirus-Positive and Human Papillomavirus-Negative Tumors. Arch Pathol Lab Med. 2017; 141(12):1653-1667. DOI: 10.5858/arpa.2016-0356-RA. View

12.

Dahlstrom L, Ylitalo N, Sundstrom K, Palmgren J, Ploner A, Eloranta S . Prospective study of human papillomavirus and risk of cervical adenocarcinoma. Int J Cancer. 2010; 127(8):1923-30. PMC: 2930102. DOI: 10.1002/ijc.25408. View

13.

Stolnicu S, Barsan I, Hoang L, Patel P, Terinte C, Pesci A . International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix. Am J Surg Pathol. 2017; 42(2):214-226. PMC: 5762258. DOI: 10.1097/PAS.0000000000000986. View

14.

Hodgson A, Olkhov-Mitsel E, Howitt B, Nucci M, Parra-Herran C . International Endocervical Adenocarcinoma Criteria and Classification (IECC): correlation with adverse clinicopathological features and patient outcome. J Clin Pathol. 2019; 72(5):347-353. DOI: 10.1136/jclinpath-2018-205632. View

15.

Stolnicu S, Barsan I, Hoang L, Patel P, Terinte C, Pesci A . Stromal invasion pattern identifies patients at lowest risk of lymph node metastasis in HPV-associated endocervical adenocarcinomas, but is irrelevant in adenocarcinomas unassociated with HPV. Gynecol Oncol. 2018; 150(1):56-60. PMC: 6615482. DOI: 10.1016/j.ygyno.2018.04.570. View

16.

Baalbergen A, Smedts F, Ewing P, Snijders P, Meijer C, Helmerhorst T . HPV-type has no impact on survival of patients with adenocarcinoma of the uterine cervix. Gynecol Oncol. 2012; 128(3):530-4. DOI: 10.1016/j.ygyno.2012.12.013. View

17.

Hodgson A, Amemiya Y, Seth A, Cesari M, Djordjevic B, Parra-Herran C . Genomic abnormalities in invasive endocervical adenocarcinoma correlate with pattern of invasion: biologic and clinical implications. Mod Pathol. 2017; 30(11):1633-1641. DOI: 10.1038/modpathol.2017.80. View

18.

Dong F, Kojiro S, Borger D, Growdon W, Oliva E . Squamous Cell Carcinoma of the Vulva: A Subclassification of 97 Cases by Clinicopathologic, Immunohistochemical, and Molecular Features (p16, p53, and EGFR). Am J Surg Pathol. 2015; 39(8):1045-53. DOI: 10.1097/PAS.0000000000000454. View

19.

McAlpine J, Leung S, Cheng A, Miller D, Talhouk A, Gilks C . Human papillomavirus (HPV)-independent vulvar squamous cell carcinoma has a worse prognosis than HPV-associated disease: a retrospective cohort study. Histopathology. 2017; 71(2):238-246. DOI: 10.1111/his.13205. View

20.

Wentzensen N, Vinokurova S, von Knebel Doeberitz M . Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res. 2004; 64(11):3878-84. DOI: 10.1158/0008-5472.CAN-04-0009. View